Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
RENUKA UMASHANKER
Listed Specialty: Gastroenterology
2200 WHITNEY AVE, SUITE 360, HAMDEN, CT, 06518-3691
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
DR. RENUKA UMASHANKER,
Yearly Payment Breakdown:
2018 Payments At a Glance
79
payments
$24,773
payment total
12
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Promotional Speaking/Other |
8 | $16,613 |
Nonaccredited Training |
2 | $4,200 |
Travel and Lodging |
6 | $2,480 |
Food and Beverage |
63 | $1,481 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
EPCLUSA |
drug |
$10,013 |
MAVYRET |
drug |
$6,762 |
XIFAXAN |
drug |
$5,897 |
Payments with no listed product |
N/A |
$1,370 |
VOSEVI |
drug |
$350 |
LINZESS |
drug |
$52 |
AMITIZA |
drug |
$51 |
INJECTAFER |
drug |
$50 |
HUMIRA |
drug |
$49 |
SAXENDA |
drug |
$43 |
TRULANCE |
drug |
$41 |
NASCOBAL |
drug |
$26 |
OCALIVA |
drug |
$21 |
UCERIS |
drug |
$20 |
DOPTELET |
drug |
$15 |
INFLECTRA |
drug |
$12 |
CREON |
drug |
$2 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Nov 6, 2018 | $3,250 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Jun 5, 2018 | $3,250 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| May 3, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Jul 30, 2018 | $3,000 | XIFAXAN | Nonaccredited Training | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 20, 2018 | $2,500 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Oct 1, 2018 | $2,500 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Mar 29, 2018 | $1,500 | XIFAXAN | Promotional Speaking/Other | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | Physicians Alliance of Connecticut |
| Oct 29, 2018 | $1,200 | No Listed Product | Nonaccredited Training | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| May 5, 2018 | $778 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Jul 20, 2018 | $647 | XIFAXAN | Travel and Lodging | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| May 5, 2018 | $551 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Jan 31, 2018 | $350 | VOSEVI | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Mar 23, 2018 | $263 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Jul 20, 2018 | $259 | XIFAXAN | Travel and Lodging | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| May 5, 2018 | $125 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Jul 20, 2018 | $125 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 20, 2018 | $120 | XIFAXAN | Travel and Lodging | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Sep 27, 2018 | $104 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| Jul 19, 2018 | $100 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| May 31, 2018 | $91 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Nov 1, 2018 | $75 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Dec 13, 2018 | $61 | No Listed Product | Food and Beverage | NOVO NORDISK INC | |
| Jul 21, 2018 | $50 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| May 5, 2018 | $49 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| May 5, 2018 | $44 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| Jul 21, 2018 | $44 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 21, 2018 | $35 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| May 3, 2018 | $24 | TRULANCE | Food and Beverage | SYNERGY PHARMACEUTICALS INC | |
| Jul 9, 2018 | $22 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Dec 24, 2018 | $21 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Sep 26, 2018 | $21 | OCALIVA | Food and Beverage | INTERCEPT PHARMACEUTICALS, INC. | |
| Apr 25, 2018 | $21 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Jun 26, 2018 | $20 | UCERIS | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Aug 3, 2018 | $19 | LINZESS | Food and Beverage | ALLERGAN INC. | |
| Apr 2, 2018 | $19 | HUMIRA | Food and Beverage | ABBVIE, INC. | |
| May 10, 2018 | $19 | LINZESS | Food and Beverage | ALLERGAN INC. | |
| May 31, 2018 | $18 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 1, 2018 | $18 | INJECTAFER | Food and Beverage | DAIICHI SANKYO INC. | |
| Aug 28, 2018 | $18 | No Listed Product | Food and Beverage | ABBVIE, INC. | |
| Jul 19, 2018 | $17 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Aug 21, 2018 | $17 | INJECTAFER | Food and Beverage | DAIICHI SANKYO INC. | |
| Jun 30, 2018 | $17 | TRULANCE | Food and Beverage | SYNERGY PHARMACEUTICALS INC | |
| Jan 22, 2018 | $16 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Nov 20, 2018 | $16 | HUMIRA | Food and Beverage | ABBVIE, INC. | |
| Oct 31, 2018 | $16 | SAXENDA | Food and Beverage | NOVO NORDISK INC | |
| Nov 28, 2018 | $16 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| May 30, 2018 | $16 | SAXENDA | Food and Beverage | NOVO NORDISK INC | |
| Jul 3, 2018 | $15 | AMITIZA | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Dec 18, 2018 | $15 | DOPTELET | Food and Beverage | DOVA PHARMACEUTICALS | |
| Jun 7, 2018 | $15 | INJECTAFER | Food and Beverage | DAIICHI SANKYO INC. | |
| Jul 21, 2018 | $15 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Apr 26, 2018 | $14 | LINZESS | Food and Beverage | ALLERGAN INC. | |
| Jun 11, 2018 | $14 | HUMIRA | Food and Beverage | ABBVIE, INC. | |
| Jun 1, 2018 | $14 | NASCOBAL | Food and Beverage | ENDO PHARMACEUTICALS INC. | |
| Feb 26, 2018 | $14 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Jul 11, 2018 | $14 | AMITIZA | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Oct 1, 2018 | $12 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Oct 22, 2018 | $12 | NASCOBAL | Food and Beverage | ENDO PHARMACEUTICALS INC. | |
| Feb 27, 2018 | $12 | SAXENDA | Food and Beverage | NOVO NORDISK INC | |
| Oct 23, 2018 | $12 | AMITIZA | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Dec 10, 2018 | $12 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 22, 2018 | $12 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Nov 8, 2018 | $12 | INFLECTRA | Food and Beverage | PFIZER INC. | |
| Jul 18, 2018 | $12 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Jul 21, 2018 | $11 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Dec 18, 2018 | $11 | AMITIZA | Food and Beverage | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
| Apr 11, 2018 | $10 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| May 14, 2018 | $9 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Jun 18, 2018 | $9 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Jul 21, 2018 | $9 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| May 31, 2018 | $9 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Oct 25, 2018 | $8 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Apr 3, 2018 | $7 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Dec 21, 2018 | $7 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Sep 6, 2018 | $7 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Jul 20, 2018 | $5 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 20, 2018 | $5 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Nov 9, 2018 | $3 | No Listed Product | Food and Beverage | ABBVIE, INC. | |
| Jul 10, 2018 | $2 | CREON | Food and Beverage | ABBVIE, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.